Herbas VPB

Print
EN | LT
LT - ANTI-CANCER REGIMEN USING ANTI-CD47 AND ANTI-CD20 ANTIBODIES
EN - ANTI-CANCER REGIMEN USING ANTI-CD47 AND ANTI-CD20 ANTIBODIES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/395 (2006.01)
A61K 39/39558 (2013.01)
C07K 16/28 (2006.01)
A61K2039/505 (2013.01)
A61P 35/00 (2006.01)
A61K2039/55 (2013.01)
A61K2039/804 (2018.08)
C07K 16/2887 (2013.01)
A61P 35/00 (2018.01)
A61K2039/545 (2013.01)
C07K 16/2803 (2013.01)
A61K2039/507 (2013.01)
European patent
(11) Number of the document 3752190
(13) Kind of document T
(96) European patent application number 19709818.9
Date of filing the European patent application 2019-02-11
(97) Date of publication of the European application 2020-12-23
(45) Date of publication and mention of the grant of the patent 2022-07-06
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2019/017466
Date 2019-02-11
PCT application publication
(87) Number WO 2019/157432
Date 2019-08-15
Priority applications
(30) Number Date Country code
201862629340 P 2018-02-12 US
201862678468 P 2018-05-31 US
201862743060 P 2018-10-09 US
201862743875 P 2018-10-10 US
Inventors
(72)
CHAO, Mark Ping , US
TAKIMOTO, Chris Hidemi Mizufune , US
VOLKMER, Jens-Peter , US
Grantee
(73) Forty Seven, Inc. , 333 Lakeside Drive, Foster City, CA 94404, US
Title
(54) ANTI-CANCER REGIMEN USING ANTI-CD47 AND ANTI-CD20 ANTIBODIES
  ANTI-CANCER REGIMEN USING ANTI-CD47 AND ANTI-CD20 ANTIBODIES